The effect of tunicamycin (TM), a nucleoside antibiotic, known to inhibit growth of a number of virus, protozoan and metazoan organisms, presumably by intervening in the glycosylation of glycoproteins, has been studied on Limnaea egg cells and rabbit erythrocytes. TM decreases the adhesion of cells in Limnaea morula and, apparently, induces a high degree of membrane permeability probably leading to the extrusion of cytoplasmic material. The effect of TM is more specific on mature rabbit erythrocytes which have no subcellular structure. TM treatment in vitro alters the normal biconcave disc-shaped erythrocytes successively into crenated discs, crenated spheres, and smooth spheres. This type of transformation is known to be caused by a number of substances but the present report is the first to indicate a nucleoside-containing compound. This irreversible reaction may be attributed to a structural change of the cellular membrane of erythrocytes.

Keywords:
Tunicamycin, Erythrocyte, Cell shape transformation, Echinocyte, Limnaea (mollusc) embryo, Cell adhesion
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.